Piramal Pharma Sellersville Plant Clears US FDA GMP Inspection With Clean Outcome

Piramal Pharma's Pennsylvania injectable CDMO site exits FDA scrutiny with NAI/VAI status, eliminating Warning Letter risk and bolstering North American contract manufacturing revenue visibility.

ndtv-profit-business · 7/9/2026, 9:06:30 AM · Ask about this →